Company intelligence / Profile preview

Radialogica

St. Louis, Missouri, United States

Ownership: Private
Development stage: Other

Overview

Radialogica provides clinically validated software tools, notably SciMoCa, for real-time quality assurance and independent dose calculation in radiation oncology, with pre-clinical and clinical validation at leading cancer centers. Their technology is integrated with MR-Linac systems to support advanced, adaptive treatments and is utilized globally by health providers and clinical trial sponsors.[1][3]

Therapeutic areas: Oncology
Modalities: DeviceSoftware tool
Industry: Digital Health Medical Devices

Partnerships

Scientific RTPerceptive Imaging/Perceptive Group

Beyond the preview

Go deeper on Radialogica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radialogica.

Explore the full profile